160 related articles for article (PubMed ID: 26423801)
1. Predictors of survival and effect of short (40 Gy) or standard-course (60 Gy) irradiation plus concomitant temozolomide in elderly patients with glioblastoma: a multicenter retrospective study of AINO (Italian Association of Neuro-Oncology).
Lombardi G; Pace A; Pasqualetti F; Rizzato S; Faedi M; Anghileri E; Nicolotto E; Bazzoli E; Bellu L; Villani V; Fabi A; Ferrazza P; Gurrieri L; Dall'Agata M; Eoli M; Della Puppa A; Pambuku A; D'Avella D; Berti F; Rudà R; Zagonel V
J Neurooncol; 2015 Nov; 125(2):359-67. PubMed ID: 26423801
[TBL] [Abstract][Full Text] [Related]
2. Patients Affected by Unmethylated O(6)-Methylguanine-DNA Methyltransferase Glioblastoma Undergoing Radiochemotherapy May Benefit from Moderately Dose-Escalated Radiotherapy.
Tini P; Nardone V; Pastina P; Battaglia G; Miracco C; Sebaste L; Rubino G; Cerase A; Pirtoli L
Biomed Res Int; 2017; 2017():9461402. PubMed ID: 29159183
[TBL] [Abstract][Full Text] [Related]
3. Treatment options and outcomes for glioblastoma in the elderly patient.
Arvold ND; Reardon DA
Clin Interv Aging; 2014; 9():357-67. PubMed ID: 24591820
[TBL] [Abstract][Full Text] [Related]
4. Radiation and concomitant chemotherapy for patients with glioblastoma multiforme.
Villà S; Balañà C; Comas S
Chin J Cancer; 2014 Jan; 33(1):25-31. PubMed ID: 24325790
[TBL] [Abstract][Full Text] [Related]
5. A population-based study on the effect of temozolomide in the treatment of glioblastoma multiforme.
Rønning PA; Helseth E; Meling TR; Johannesen TB
Neuro Oncol; 2012 Sep; 14(9):1178-84. PubMed ID: 22869622
[TBL] [Abstract][Full Text] [Related]
6. Outcome-based determination of optimal pyrosequencing assay for MGMT methylation detection in glioblastoma patients.
Quillien V; Lavenu A; Sanson M; Legrain M; Dubus P; Karayan-Tapon L; Mosser J; Ichimura K; Figarella-Branger D
J Neurooncol; 2014 Feb; 116(3):487-96. PubMed ID: 24420923
[TBL] [Abstract][Full Text] [Related]
7. Patterns of relapse in glioblastoma multiforme following concomitant chemoradiotherapy with temozolomide.
Sherriff J; Tamangani J; Senthil L; Cruickshank G; Spooner D; Jones B; Brookes C; Sanghera P
Br J Radiol; 2013 Feb; 86(1022):20120414. PubMed ID: 23385995
[TBL] [Abstract][Full Text] [Related]
8. REGOMA-OSS: a large, Italian, multicenter, prospective, observational study evaluating the efficacy and safety of regorafenib in patients with recurrent glioblastoma.
Caccese M; Desideri I; Villani V; Simonelli M; Buglione M; Chiesa S; Franceschi E; Gaviani P; Stasi I; Caserta C; Brugnara S; Lolli I; Bennicelli E; Bini P; Cuccu AS; Scoccianti S; Padovan M; Gori S; Bonetti A; Giordano P; Pellerino A; Gregucci F; Riva N; Cinieri S; Internò V; Santoni M; Pernice G; Dealis C; Stievano L; Paiar F; Magni G; De Salvo GL; Zagonel V; Lombardi G
ESMO Open; 2024 Apr; 9(4):102943. PubMed ID: 38492275
[TBL] [Abstract][Full Text] [Related]
9. Exploring management and outcomes of elderly patients with glioblastoma using data from two randomised trials (GEINO1401/EX-TEM).
Gately L; Mesía C; Sepúlveda JM; Del Barco S; Pineda E; Gironés R; Fuster J; Dumas M; Gill S; Navarro LM; Herrero A; Dowling A; de Las Peñas R; Vaz MA; Alonso M; Lwin Z; Harrup R; Peralta S; Long A; Perez-Segura P; Ahern E; Garate CO; Wong M; Campbell R; Cuff K; Jennens R; Gallego O; Underhill C; Martinez-Garcia M; Covela M; Cooper A; Brown S; Rosenthal M; Torres J; Collins IM; Gibbs P; Balana C
J Neurooncol; 2024 Jun; 168(2):299-306. PubMed ID: 38630385
[TBL] [Abstract][Full Text] [Related]
10. The evolution of the EGFRvIII (rindopepimut) immunotherapy for glioblastoma multiforme patients.
Paff M; Alexandru-Abrams D; Hsu FP; Bota DA
Hum Vaccin Immunother; 2014; 10(11):3322-31. PubMed ID: 25625931
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic radiosurgery for glioblastoma considering tumor genetic profiles: an international multicenter study.
Bunevicius A; Pikis S; Kondziolka D; Patel DN; Bernstein K; Sulman EP; Lee CC; Yang HC; Delabar V; Mathieu D; Cifarelli CP; Arsanious DE; Dahshan BA; Weir JS; Speckter H; Mota A; Tripathi M; Kumar N; Warnick RE; Sheehan JP
J Neurosurg; 2022 Jul; 137(1):42-50. PubMed ID: 34740186
[TBL] [Abstract][Full Text] [Related]
12. Glioblastoma in the Canton of Zurich, Switzerland revisited: 2005 to 2009.
Gramatzki D; Dehler S; Rushing EJ; Zaugg K; Hofer S; Yonekawa Y; Bertalanffy H; Valavanis A; Korol D; Rohrmann S; Pless M; Oberle J; Roth P; Ohgaki H; Weller M
Cancer; 2016 Jul; 122(14):2206-15. PubMed ID: 27088883
[TBL] [Abstract][Full Text] [Related]
13. Treatment of very elderly glioblastoma patients ≥ 75 years of age: whom to treat.
Baumgarten P; Prange G; Kamp MA; Monden D; Neef V; Schwarzer F; Dubinski D; Dinc N; Weber KJ; Czabanka M; Hattingen E; Ronellenfitsch MW; Steinbach JP; Senft C
J Neurooncol; 2023 Dec; 165(3):509-515. PubMed ID: 38032426
[TBL] [Abstract][Full Text] [Related]
14. Radiotherapy-induced glioblastoma: distinct differences in overall survival, tumor location, pMGMT methylation and primary tumor epidemiology in Hong Kong chinese patients.
Woo PYM; Lee JWY; Lam SW; Pu JKS; Chan DTM; Mak CHK; Ho JMK; Wong ST; Po YC; Lee MWY; Chan KY; Poon WS
Br J Neurosurg; 2024 Apr; 38(2):385-392. PubMed ID: 33576706
[TBL] [Abstract][Full Text] [Related]
15. Is IDH status the only factor predicting prognosis in newly diagnosed anaplastic glioma patients? Outcome evaluation and prognostic factor analysis in a single-institution large series.
Navarria P; Pessina F; Clerici E; Rossini Z; Franceschini D; D'Agostino G; Franzese C; Comito T; Loi M; Simonelli M; Lorenzi E; Persico P; Politi LS; Grimaldi M; Bello L; Santoro A; Fornari M; Servadei F; Scorsetti M
J Neurosurg; 2020 Sep; 135(1):64-77. PubMed ID: 32886916
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic interactions of autophagy with radiation and temozolomide in glioblastoma: evidence and issues to resolve.
Koukourakis MI; Mitrakas AG; Giatromanolaki A
Br J Cancer; 2016 Mar; 114(5):485-96. PubMed ID: 26889975
[TBL] [Abstract][Full Text] [Related]
17. SSBP2 variants are associated with survival in glioblastoma patients.
Xiao Y; Decker PA; Rice T; McCoy LS; Smirnov I; Patoka JS; Hansen HM; Wiemels JL; Tihan T; Prados MD; Chang SM; Berger MS; Kosel ML; Fridley BL; Lachance DH; O'Neill BP; Buckner JC; Thompson RC; Nabors LB; Olson JJ; Brem S; Madden MH; Browning JE; Wiencke JK; Egan KM; Jenkins RB; Wrensch MR
Clin Cancer Res; 2012 Jun; 18(11):3154-62. PubMed ID: 22472174
[TBL] [Abstract][Full Text] [Related]
18. Glioblastoma in the elderly: treatment patterns and survival.
Pretanvil JA; Salinas IQ; Piccioni DE
CNS Oncol; 2017 Jan; 6(1):19-28. PubMed ID: 28001088
[TBL] [Abstract][Full Text] [Related]
19. Predictors of Tumor Dynamics Over a 6-Week Course of Concurrent Chemoradiotherapy for Glioblastoma and the Effect on Survival.
Ong WL; Stewart J; Sahgal A; Soliman H; Tseng CL; Detsky J; Chen H; Ho L; Das S; Maralani P; Lipsman N; Stanisz G; Perry J; Lim-Fat MJ; Atenafu EG; Lau A; Ruschin M; Myrehaug S
Int J Radiat Oncol Biol Phys; 2024 Mar; ():. PubMed ID: 38561051
[TBL] [Abstract][Full Text] [Related]
20. Management and outcomes of glioblastoma: 20-year experience in a single Australian institution.
Lenffer B; Ruben J; Senthi S; Millar J; Ong WL
J Med Imaging Radiat Oncol; 2024 Mar; 68(2):208-216. PubMed ID: 37997616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
